Clinical Trial Update: Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating the efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in HIV-1 infected adolescents; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide

Snippet

Sponsor: Gilead Sciences | Conditions: HIV | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-02-22